Effects of Alzheimer's disease plasma marker levels on multilayer centrality in healthy individuals
Alejandra García‐Colomo, David López‐Sanz, Ignacio Taguas…·Fernando Maestú
This study examines how Alzheimer's disease plasma markers affect multilayer centrality in healthy individuals at risk, finding increased centrality in posterior regions and hub vulnerability to p-tau231.